Total Payments
$4,811
2024 Payments
$691.26
Companies
41
Transactions
336
Medicare Patients
41,823
Medicare Billing
$2.7M
Payment Breakdown by Category
Food & Beverage$4,773 (99.2%)
Education$37.50 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,773 | 333 | 99.2% |
| Education | $37.50 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $718.14 | 51 | $0 (2024) |
| ABBVIE INC. | $491.48 | 48 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $446.09 | 23 | $0 (2024) |
| PFIZER INC. | $385.69 | 50 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $330.93 | 10 | $0 (2023) |
| Lilly USA, LLC | $314.81 | 17 | $0 (2024) |
| Amarin Pharma Inc. | $232.51 | 16 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $209.30 | 15 | $0 (2019) |
| Novo Nordisk Inc | $153.41 | 11 | $0 (2024) |
| Allergan, Inc. | $142.31 | 10 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $691.26 | 35 | Lilly USA, LLC ($111.62) |
| 2023 | $886.21 | 67 | PFIZER INC. ($159.24) |
| 2022 | $582.36 | 44 | ABBVIE INC. ($191.25) |
| 2021 | $526.87 | 32 | AbbVie Inc. ($142.25) |
| 2020 | $282.76 | 16 | AstraZeneca Pharmaceuticals LP ($124.55) |
| 2019 | $537.44 | 36 | Amgen Inc. ($169.21) |
| 2018 | $740.53 | 68 | Amgen Inc. ($202.41) |
| 2017 | $563.36 | 38 | Novartis Pharmaceuticals Corporation ($117.56) |
All Payment Transactions
336 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Biological | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Diabetes Care | ||||||
| 09/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Bone Health | ||||||
| 09/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: DIABETES | ||||||
| 08/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Endocrinology | ||||||
| 08/06/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: DIABETES | ||||||
| 07/24/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $76.36 | General |
| Category: Obesity | ||||||
| 06/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $25.15 | General |
| Category: Cardiovascular | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 05/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.65 | General |
| 05/28/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Neurology | ||||||
| 05/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.59 | General |
| 05/07/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Endocrinology | ||||||
| 05/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/26/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Bone Health | ||||||
| 04/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 70 | 9,908 | 49,632 | $2.3M | $865,218 |
| 2022 | 77 | 10,786 | 29,790 | $2.1M | $675,953 |
| 2021 | 69 | 10,276 | 26,056 | $1.8M | $608,524 |
| 2020 | 72 | 10,853 | 27,403 | $1.9M | $586,380 |
Total Patients
41,823
Total Services
132,881
Medicare Billing
$2.7M
Procedure Codes
288
All Medicare Procedures & Services
288 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 119 | 11,940 | $298,500 | $218,298 | 73.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 686 | 2,145 | $525,305 | $183,111 | 34.9% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 15 | 19,530 | $292,950 | $155,037 | 52.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 399 | 399 | $87,780 | $49,538 | 56.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 442 | 761 | $132,875 | $42,450 | 31.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 323 | 329 | $24,755 | $23,624 | 95.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 751 | 2,440 | $49,410 | $20,457 | 41.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 748 | 1,933 | $202,965 | $19,857 | 9.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 630 | 1,108 | $95,288 | $18,197 | 19.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 692 | 1,280 | $115,200 | $16,723 | 14.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 730 | 1,528 | $73,344 | $11,548 | 15.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 42 | 42 | $13,650 | $11,536 | 84.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 330 | 337 | $11,795 | $9,945 | 84.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 424 | 1,021 | $62,281 | $9,626 | 15.5% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 172 | 230 | $37,490 | $9,274 | 24.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 59 | $20,355 | $7,077 | 34.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 178 | 208 | $51,500 | $5,984 | 11.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 173 | 375 | $15,938 | $3,994 | 25.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 411 | 528 | $31,490 | $2,979 | 9.5% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 199 | 329 | $17,273 | $2,908 | 16.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 13 | $5,135 | $2,790 | 54.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 214 | 323 | $28,424 | $2,678 | 9.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $2,850 | $2,417 | 84.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $4,875 | $2,412 | 49.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 14 | $3,920 | $2,218 | 56.6% |
About Dr. Pui-Sum Wong, M.D
Dr. Pui-Sum Wong, M.D is a Internal Medicine healthcare provider based in Texarkana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912975111.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pui-Sum Wong, M.D has received a total of $4,811 in payments from pharmaceutical and medical device companies, with $691.26 received in 2024. These payments were reported across 336 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($4,773).
As a Medicare-enrolled provider, Wong has provided services to 41,823 Medicare beneficiaries, totaling 132,881 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 288 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Texarkana, TX
- Active Since 03/14/2006
- Last Updated 04/20/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1912975111
Products in Payments
- ELIQUIS (Drug) $371.59
- Aimovig (Biological) $256.66
- XARELTO (Drug) $240.15
- ENTRESTO (Drug) $237.93
- Vascepa (Drug) $232.51
- EVENITY (Biological) $210.63
- LEQVIO (Drug) $208.16
- QULIPTA (Drug) $206.56
- JARDIANCE (Drug) $159.92
- UBRELVY (Drug) $159.72
- Repatha (Biological) $155.20
- FARXIGA (Drug) $138.16
- VRAYLAR (Drug) $137.70
- SOLIQUA (Drug) $100.98
- INVOKANA (Drug) $90.78
- XIFAXAN (Drug) $89.85
- Dexcom G6 Transmitter (Medical Supply) $88.54
- LINZESS (Drug) $82.90
- Prolia (Biological) $82.37
- ZEPBOUND (Drug) $76.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Texarkana
Dr. Sunil Patel, M.d, M.D
Internal Medicine — Payments: $17,072
Internal Medicine $17,072
Gary Engstrom, Md, MD
Internal Medicine — Payments: $14,734
Internal Medicine $14,734
Dr. Gregory White, Md, MD
Internal Medicine — Payments: $12,091
Internal Medicine $12,091
Rajeev Patel, M.d, M.D
Internal Medicine — Payments: $8,180
Internal Medicine $8,180
Poongodhai Ramachandran, Md, MD
Internal Medicine — Payments: $5,002
Internal Medicine $5,002
John Griffin, Md, MD
Internal Medicine — Payments: $4,034
Internal Medicine $4,034